Skip to main content

Table 2 Patient and tumor characteristics

From: Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Patient cohortTotal n = 77
Gender, n (%)
 Male53 (69)
 Female24 (31)
Age at diagnosis, years
 Median (range)62 (40–76)
Age at metastatic disease, years
 Median (range)64,5 (40–77)
Histologictype, n (%)
 Clear cell68 (88)
 Papillary2 (3)
 Mixed phenotype2 (3)
 Unknown5 (6)
Local disease at diagnosis, n (%)36 (47)
Metastatic disease at diagnosis, n (%)41 (53)
Time to metastasis, years
 Median (range)2 (0–18)
Metastasis during first year, n (%)14 (39)
Metastasis after first year, n (%)22 (61)
Alive, n (%)16 (21)
Dead, n (%)61 (79)